PortfoliosLab logo

Adaptive Biotechnologies Corporation (ADPT)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Adaptive Biotechnologies Corporation in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,988 for a total return of roughly -80.12%. All prices are adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%NovemberDecember2023FebruaryMarch
10.51%
6.48%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADPT

Popular comparisons: ADPT vs. SPY

Return

Adaptive Biotechnologies Corporation had a return of 4.84% year-to-date (YTD) and -30.77% in the last 12 months. Over the past 10 years, Adaptive Biotechnologies Corporation had an annualized return of -35.24%, while the S&P 500 had an annualized return of 8.17%, indicating that Adaptive Biotechnologies Corporation did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-7.72%-5.31%
Year-To-Date4.84%2.01%
6 months-5.09%0.39%
1 year-30.77%-10.12%
5 years (annualized)-35.24%8.17%
10 years (annualized)-35.24%8.17%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202321.34%-7.77%
2022-20.18%9.27%12.85%-12.98%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adaptive Biotechnologies Corporation Sharpe ratio is -0.34. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20NovemberDecember2023FebruaryMarch
-0.34
-0.43
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Dividend History


Adaptive Biotechnologies Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-88.18%
-18.34%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adaptive Biotechnologies Corporation is 90.76%, recorded on Oct 14, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.76%Jan 25, 2021436Oct 14, 2022
-68.3%Sep 5, 2019133Mar 16, 2020188Dec 10, 2020321
-27.29%Jul 1, 201925Aug 5, 201918Aug 29, 201943
-14.85%Dec 24, 20207Jan 5, 20217Jan 14, 202114
-2.05%Dec 15, 20201Dec 15, 20202Dec 17, 20203
-0.85%Jan 15, 20211Jan 15, 20211Jan 19, 20212
-0.71%Jan 20, 20211Jan 20, 20212Jan 22, 20213

Volatility Chart

Current Adaptive Biotechnologies Corporation volatility is 62.68%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%NovemberDecember2023FebruaryMarch
62.68%
21.17%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)